Tower Research Capital LLC (Trc) Oncorus, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.28 - $0.45 $5 - $9	-21 Reduced 0.24%	8,581 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.24 - $0.76 $613 - $1,941	-2,555 Reduced 22.9%	8,602 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.85 - $1.65 $2,426 - $4,710	2,855 Added 34.39%	11,157 $9,000
Q2 2022 Aug 15, 2022	BUY	$1.04 - $1.86 $1,564 - $2,797	1,504 Added 22.12%	8,302 $10,000
Q1 2022 May 12, 2022	SELL	$1.44 - $5.62 $7,395 - $28,864	-5,136 Reduced 43.04%	6,798 $12,000
Q4 2021 Feb 14, 2022	BUY	$5.03 - $11.63 $14,833 - $34,296	2,949 Added 32.82%	11,934 $63,000
Q3 2021 Nov 15, 2021	BUY	$9.29 - $14.27 $64,156 - $98,548	6,906 Added 332.18%	8,985 $84,000
Q2 2021 Aug 16, 2021	BUY	$13.3 - $17.3 $13,127 - $17,075	987 Added 90.38%	2,079 $29,000
Q1 2021 May 17, 2021	BUY	$11.89 - $35.55 $11,093 - $33,168	933 Added 586.79%	1,092 $15,000
Q4 2020 Feb 16, 2021	BUY	$15.0 - $35.15 $2,385 - $5,588	159 New	159 $5,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.